Sickle Cell Disease Comprehensive Care Act
- Sponsor
- Rep. Dunn, Neal P. [R-FL-2]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Sep 8, 2025
Bottom line
This bill expands Medicaid health home services to specifically include individuals with sickle cell disease, mandating comprehensive care including dental and vision services, and requiring outcome reporting.
What it actually does
This bill amends Title XIX of the Social Security Act to allow State Medicaid programs to establish "health homes" specifically for individuals with sickle cell disease, effective January 1, 2026. These health homes would provide comprehensive, coordinated care, including mandatory dental and vision services, regardless of whether the state typically provides these to other Medicaid beneficiaries. States would also be required to report on the quality, access, and expenditures of care for these individuals.
Proponents argue
Proponents argue this bill addresses a critical gap in coordinated care for individuals with sickle cell disease, a severe genetic disorder requiring complex, multidisciplinary management. By establishing dedicated health homes and mandating essential services like dental and vision care, it would improve health outcomes, reduce emergency room visits, and enhance the quality of life for a vulnerable population often facing significant health disparities.
Opponents contend
Potential opponents might express concerns about the financial implications for states, particularly the mandate to provide dental and vision services irrespective of existing state Medicaid benefits, which could increase state expenditures. They might also question the administrative burden of establishing new disease-specific health homes and the reporting requirements, suggesting that existing Medicaid structures could be adapted without creating a new category.
The bill is very short and can be read quickly, allowing ample time for evaluation.
Section 2(1) and 2(2)(A) amending Section 1945(a) and (c)(1) of the Social Security Act
Eligibility for Sickle Cell Disease Health Homes
This provision expands the existing Medicaid health home program, which currently serves individuals with chronic conditions, to explicitly include "eligible individuals with sickle cell disease" starting January 1, 2026. This means states can receive federal matching funds to provide comprehensive, coordinated care through health homes specifically designed for this population.
Supporters argue
Supporters argue this is crucial for addressing the complex, lifelong care needs of sickle cell patients, who often experience fragmented care, leading to poorer health outcomes and higher costs. Dedicated health homes can provide integrated medical, behavioral, and social support.
Critics contend
No specific opposition is typically raised against expanding eligibility for health home services when federal matching funds are available, as it is generally seen as a beneficial expansion of care. However, some might raise concerns about the administrative burden on states.
Tradeoffs
Balances the need for specialized care for a vulnerable population against the administrative and financial implications for state Medicaid programs.
Section 2(2)(B) amending Section 1945(c)(5)(B) of the Social Security Act
Mandatory Dental and Vision Services for Sickle Cell Disease Health Homes
For any state plan amendment approved for sickle cell disease health homes on or after January 1, 2026, the state must ensure the provision of dental and vision services to enrolled individuals. This requirement applies even if the state does not typically provide these services to other Medicaid beneficiaries or if existing comparability rules would normally exempt them.
Section 2(2)(C) amending Section 1945(c)(5)(C) of the Social Security Act
Reporting Requirements for Sickle Cell Disease Health Homes
States with approved sickle cell disease-focused health home amendments must submit a report to the Secretary of Health and Human Services by the end of the 8th fiscal year quarter (two years) after the amendment takes effect. This report must detail the quality of care, access to care, and total health care expenditures for enrolled individuals with sickle cell disease, using measures specified by the Secretary.
Section 2(2)(D) amending Section 1945(c)(5)(D) of the Social Security Act
CMS Best Practices for Sickle Cell Disease Health Homes
By June 30, 2026, the Secretary of Health and Human Services (via CMS) must publish best practices for designing and implementing sickle cell disease-focused state plan amendments. This guidance will be based on clinical practice guidelines from medical specialty societies and developed in consultation with sickle cell disease providers and patient advocacy organizations.
This provision mandates that states provide dental and vision services to eligible individuals with sickle cell disease enrolled in a health home, "irrespective of existing requirements related to comparability or whether or not the State provides dental or vision services to other Medicaid beneficiaries."
Section 2(2)(B) amending Section 1945(c)(5)(B)
Why it matters:This is standard legislative practice to ensure a specific benefit is provided to a targeted population, even if it deviates from general program rules. It's not evasive but requires understanding Medicaid's foundational principles.
Case for: Supporters argue this ensures comprehensive care for a vulnerable population whose specific health needs, including dental and vision, are critical to managing their complex condition and preventing severe complications. It prioritizes patient needs over administrative consistency.
Case against: Critics, particularly state fiscal conservatives, might argue this is an unfunded mandate that bypasses established state flexibility and could set a precedent for other disease-specific carve-outs, potentially leading to increased state costs and administrative complexity.
Estimated impact: Potentially significant financial impact on states that do not currently offer comprehensive dental and vision benefits to all Medicaid beneficiaries, requiring new expenditures and provider networks.